Global Technologies Ltd. (GTLL)
OTC PINK OTC PINK Primary 
Upstream Bio, Inc. (UPB) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Upstream Bio, Inc. (UPB) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Venture Global vs. Cheniere Energy: Picking the Better LNG Play
Cheniere's scale and >95% contract coverage beat Venture Global's faster buildout and cheaper valuation in a close LNG showdown.
Lands' End: Q1 Reveals WHP Global Deal's Pros And Cons (Rating Upgrade)
Lands' End, Inc. reported very weak Q1 results due to transitory operational disruption. The hiccup isn't cause for worry but limits Q1 results' signaling value. Q1 disclosures gave much better insight into LE's joint venture with WHP Global. The partnership has clear pros and cons. LE established an FY2026 guidance and guides improved sales momentum but thinner margins due to royalty payments.
Abacus Global Management launches AI lifespan modeling platform
Abacus Global Management (NYSE:ABX) has unveiled LifeARC, a proprietary AI-powered platform that generates personalized lifespan models for individuals using medical history, medications, genetics, and biometrics. The alternative asset manager said LifeARC draws on 20 years of proprietary data to produce individualized longevity projections.
Should Global X Russell 2000 ETF (RSSL) Be on Your Investing Radar?
Designed to provide broad exposure to the Small Cap Blend segment of the US equity market, the Global X Russell 2000 ETF (RSSL) is a passively managed exchange traded fund launched on June 4, 2024.
Develop Global Limited (VTEXF) Discusses Final Investment Decisions, USD 400 Million Funding Facility, and Trafigura Collaboration Transcript
Develop Global Limited (VTEXF) Discusses Final Investment Decisions, USD 400 Million Funding Facility, and Trafigura Collaboration Transcript
Zealand Pharma A/S (ZLDPY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Zealand Pharma A/S (ZLDPY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Medline Inc. (MDLN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Medline Inc. (MDLN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Palvella Therapeutics, Inc. (PVLA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Palvella Therapeutics, Inc. (PVLA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Should You Invest in the Global X U.S. Electrification ETF (ZAP)?
Looking for broad exposure to the Energy - Broad segment of the equity market? You should consider the Global X U.S. Electrification ETF (ZAP), a passively managed exchange traded fund launched on December 17, 2024.
S&P Global: AI Adoption, Spin-Off, And Undervalued
S&P Global is rated a 'buy' as it trades below historical valuation despite robust growth, strong margins, and a 53-year dividend increase streak. SPGI's spin-off of the Mobility segment and ongoing AI investments are expected to enhance growth, margins, and business focus, with a July 2026 completion for the spin-off. Q1 2026 results exceeded expectations, with revenue up 10.3% and non-GAAP EPS up 14%, yet shares have declined 18.8% YTD amid AI disruption fears.
Selling abrdn Global Infrastructure Income Fund On Removal Of Term Structure
abrdn Global Infrastructure Income Fund has converted from a term structure to a perpetual closed-end fund, removing the guaranteed liquidity event. ASGI trades near NAV, but perpetual CEFs with illiquid holdings often develop significant NAV discounts, especially amid the current market aversion to illiquidity. The fund offers a 12%+ yield, but nearly half of distributions are return of capital, raising concerns about sustainability and risk profile.
